• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

p53功能获得性突变等位基因在前列腺癌细胞中引起的基因表达变化分析。

Profiling of gene expression changes caused by p53 gain-of-function mutant alleles in prostate cancer cells.

作者信息

Tepper Clifford G, Gregg Jeffrey P, Shi Xu-Bao, Vinall Ruth L, Baron Colin A, Ryan Philip E, Desprez Pierre-Yves, Kung Hsing-Jien, deVere White Ralph W

机构信息

Department of Biochemistry and Molecular Medicine, University of California, Davis School of Medicine, Division of Basic Sciences, UC Davis Cancer Center, Sacramento, California 95817, USA.

出版信息

Prostate. 2005 Dec 1;65(4):375-89. doi: 10.1002/pros.20308.

DOI:10.1002/pros.20308
PMID:16037992
Abstract

BACKGROUND

Tumor suppressor p53 mutations are associated with the transition of prostate cancer to metastatic, hormone-refractory disease and stable expression of p53 gain-of-function (p53GOF) alleles support growth of LNCaP in androgen-depleted medium. In this study, we performed gene expression profiling of four LNCaP-p53GOF sublines to test the hypothesis that different p53GOF mutants mediated androgen independence via modulation of a common set of genes.

METHODS

Expression profiling was performed using Affymetrix HG-U95Av2 arrays followed by hierarchical clustering to identify expression patterns associated with particular molecular alterations. p53GOF-mediated regulation of Id-1 expression was validated by RT-PCR and dual-luciferase reporter assays. RNA interference was used to investigate the effects of Id-1 and Id-3 suppression.

RESULTS

LNCaP-p53GOF sublines possessed a molecular signature consisting of 95 differentially regulated genes that could be segregated into two clusters of transcripts induced (n=50) and repressed (n=45) by p53GOF expression. To begin validating these genes as effectors of the p53 mutants, we evaluated one of the overexpressed genes, Id-1. RT-PCR confirmed the microarray results and revealed elevated Id-1 levels in LNCaP-p53-P151S (loss-of-function only mutant), thereby implicating p53 mutational inactivation, but not gain-of-function, as a basis for Id-1 deregulation. Reporter assays demonstrated enhanced Id-1 promoter activity in an LNCaP-p53GOF subline. The contribution of Id-1 to p53GOF-mediated biology was demonstrated by the ability of RNAi-mediated gene silencing to decrease both basal and androgen-independent proliferation.

CONCLUSIONS

While different p53GOF mutants result in overall distinct expression profiles, they share a common set of differentially-expressed genes that can be used to signify their presence and provide insight into mechanisms underlying androgen independence.

摘要

背景

肿瘤抑制因子p53突变与前列腺癌向转移性、激素难治性疾病的转变相关,且p53功能获得性(p53GOF)等位基因的稳定表达支持LNCaP细胞在雄激素缺乏培养基中的生长。在本研究中,我们对四个LNCaP-p53GOF亚系进行了基因表达谱分析,以检验不同的p53GOF突变体通过调控一组共同基因介导雄激素非依赖性的假说。

方法

使用Affymetrix HG-U95Av2芯片进行表达谱分析,随后进行层次聚类以识别与特定分子改变相关的表达模式。通过RT-PCR和双荧光素酶报告基因检测验证p53GOF介导的Id-1表达调控。使用RNA干扰研究Id-1和Id-3抑制的作用。

结果

LNCaP-p53GOF亚系具有一个由95个差异调节基因组成的分子特征,这些基因可分为两个转录本簇,分别由p53GOF表达诱导(n = 50)和抑制(n = 45)。为了开始验证这些基因是p53突变体的效应器,我们评估了其中一个过表达基因Id-1。RT-PCR证实了芯片结果,并揭示了LNCaP-p53-P151S(仅功能丧失突变体)中Id-1水平升高,从而表明p53突变失活而非功能获得是Id-1失调的基础。报告基因检测表明在一个LNCaP-p53GOF亚系中Id-1启动子活性增强。RNAi介导的基因沉默能够降低基础增殖和雄激素非依赖性增殖,这证明了Id-1对p53GOF介导生物学的作用。

结论

虽然不同的p53GOF突变体导致总体上不同的表达谱,但它们共享一组共同的差异表达基因,这些基因可用于表明它们的存在,并深入了解雄激素非依赖性的潜在机制。

相似文献

1
Profiling of gene expression changes caused by p53 gain-of-function mutant alleles in prostate cancer cells.p53功能获得性突变等位基因在前列腺癌细胞中引起的基因表达变化分析。
Prostate. 2005 Dec 1;65(4):375-89. doi: 10.1002/pros.20308.
2
Gene expression in the LNCaP human prostate cancer progression model: progression associated expression in vitro corresponds to expression changes associated with prostate cancer progression in vivo.LNCaP人前列腺癌进展模型中的基因表达:体外进展相关表达与体内前列腺癌进展相关的表达变化相对应。
Cancer Lett. 2006 Dec 8;244(2):274-88. doi: 10.1016/j.canlet.2005.12.027. Epub 2006 Feb 23.
3
Androgen-independent growth of LNCaP prostate cancer cells is mediated by gain-of-function mutant p53.LNCaP前列腺癌细胞的雄激素非依赖性生长由功能获得性突变型p53介导。
Cancer Res. 2003 May 1;63(9):2228-33.
4
Non-redundant inhibitor of differentiation (Id) gene expression and function in human prostate epithelial cells.人前列腺上皮细胞中分化抑制因子(Id)基因表达及功能的非冗余性
Prostate. 2006 Jun 15;66(9):921-35. doi: 10.1002/pros.20366.
5
Molecular alterations associated with LNCaP cell progression to androgen independence.与LNCaP细胞进展至雄激素非依赖性相关的分子改变。
Prostate. 2004 Aug 1;60(3):257-71. doi: 10.1002/pros.20039.
6
Id-1 expression induces androgen-independent prostate cancer cell growth through activation of epidermal growth factor receptor (EGF-R).Id-1表达通过激活表皮生长因子受体(EGF-R)诱导雄激素非依赖性前列腺癌细胞生长。
Carcinogenesis. 2004 Apr;25(4):517-25. doi: 10.1093/carcin/bgh047. Epub 2003 Dec 19.
7
Elevated levels of prostate-specific antigen (PSA) in prostate cancer cells expressing mutant p53 is associated with tumor metastasis.在表达突变型p53的前列腺癌细胞中,前列腺特异性抗原(PSA)水平升高与肿瘤转移相关。
Mol Carcinog. 2003 Nov;38(3):130-40. doi: 10.1002/mc.10154.
8
JunD mediates androgen-induced oxidative stress in androgen dependent LNCaP human prostate cancer cells.JunD在雄激素依赖的LNCaP人前列腺癌细胞中介导雄激素诱导的氧化应激。
Prostate. 2008 Jun 15;68(9):924-34. doi: 10.1002/pros.20737.
9
Expression of prostate specific antigen (PSA) is negatively regulated by p53.前列腺特异性抗原(PSA)的表达受p53负调控。
Oncogene. 2002 Jan 3;21(1):153-7. doi: 10.1038/sj.onc.1205001.
10
Heterogeneity of molecular targets on clonal cancer lines derived from a novel hormone-refractory prostate cancer tumor system.源自新型激素难治性前列腺癌肿瘤系统的克隆癌细胞系上分子靶点的异质性
Prostate. 2003 Jun 1;55(4):299-307. doi: 10.1002/pros.10226.

引用本文的文献

1
p53 and metabolism: from mechanism to therapeutics.p53与新陈代谢:从机制到治疗学
Oncotarget. 2018 May 4;9(34):23780-23823. doi: 10.18632/oncotarget.25267.
2
DMAPT inhibits NF-κB activity and increases sensitivity of prostate cancer cells to X-rays in vitro and in tumor xenografts in vivo.DMAPT 抑制 NF-κB 活性,并增加前列腺癌细胞对体内肿瘤异种移植物中 X 射线的敏感性。
Free Radic Biol Med. 2017 Nov;112:318-326. doi: 10.1016/j.freeradbiomed.2017.08.001. Epub 2017 Aug 3.
3
Hepatic stellate cell promoted hepatoma cell invasion via the HGF/c-Met signaling pathway regulated by p53.
肝星状细胞通过由p53调节的HGF/c-Met信号通路促进肝癌细胞侵袭。
Cell Cycle. 2016;15(7):886-94. doi: 10.1080/15384101.2016.1152428.
4
Comparison of effects of p53 null and gain-of-function mutations on salivary tumors in MMTV-Hras transgenic mice.p53基因缺失和功能获得性突变对MMTV-Hras转基因小鼠唾液腺肿瘤影响的比较。
PLoS One. 2015 Feb 19;10(2):e0118029. doi: 10.1371/journal.pone.0118029. eCollection 2015.
5
Id3 induces an Elk-1-caspase-8-dependent apoptotic pathway in squamous carcinoma cells.Id3在鳞状癌细胞中诱导一条依赖于Elk-1-半胱天冬酶-8的凋亡途径。
Cancer Med. 2015 Jun;4(6):914-24. doi: 10.1002/cam4.427. Epub 2015 Feb 18.
6
More targets, more pathways and more clues for mutant p53.更多的靶点、更多的通路和更多的突变型 p53 线索。
Oncogenesis. 2013 Jul 1;2(7):e54. doi: 10.1038/oncsis.2013.15.
7
A co-clinical approach identifies mechanisms and potential therapies for androgen deprivation resistance in prostate cancer.联合临床方法鉴定前列腺癌去势抵抗的机制和潜在治疗方法。
Nat Genet. 2013 Jul;45(7):747-55. doi: 10.1038/ng.2650. Epub 2013 Jun 2.
8
Mutant p53 is a transcriptional co-factor that binds to G-rich regulatory regions of active genes and generates transcriptional plasticity.突变型 p53 是一种转录共激活因子,它可以结合到活性基因的富含 G 的调控区域,从而产生转录可塑性。
Cell Cycle. 2012 Sep 1;11(17):3290-303. doi: 10.4161/cc.21646. Epub 2012 Aug 21.
9
Mutant p53 enhances MET trafficking and signalling to drive cell scattering and invasion.突变型 p53 增强 MET 转运和信号转导,从而驱动细胞扩散和侵袭。
Oncogene. 2013 Mar 7;32(10):1252-65. doi: 10.1038/onc.2012.148. Epub 2012 May 14.
10
Prediction of functional regulatory SNPs in monogenic and complex disease.单基因病和复杂疾病中功能调控 SNP 的预测。
Hum Mutat. 2011 Oct;32(10):1183-90. doi: 10.1002/humu.21559. Epub 2011 Sep 9.